Targeted therapies and PARPi therapy response following ICI therapy failure in advanced melanoma: a case series
Poly (ADP-ribose) polymerase inhibitors (PARPi) have shown efficacy in treating cancers with homologous recombination deficiency (HRD), including subsets of melanoma. However, the potential synergy between PARPi and standard melanoma therapies remains understudied. Here, we report two cases of advan...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2025-12-01
|
| Serier: | Melanoma Management |
| Fag: | |
| Online adgang: | https://www.tandfonline.com/doi/10.1080/20450885.2025.2598476 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
